{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:25:02Z","timestamp":1789154702773,"version":"build-2803163510"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Funds for Regional Development","award":["EFRE\/IWB 20102-F1900731-KZP"],"award-info":[{"award-number":["EFRE\/IWB 20102-F1900731-KZP"]}]},{"DOI":"10.13039\/501100017569","name":"Salzburger Landesregierung","doi-asserted-by":"publisher","award":["WISS2025 F2200397-KZP"],"award-info":[{"award-number":["WISS2025 F2200397-KZP"]}],"id":[{"id":"10.13039\/501100017569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017569","name":"Salzburger Landesregierung","doi-asserted-by":"publisher","award":["WISS2025 P1812596"],"award-info":[{"award-number":["WISS2025 P1812596"]}],"id":[{"id":"10.13039\/501100017569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>An intronic G4C2 repeat expansion in the C9ORF72 gene is the major known cause for Amyotrophic Lateral Sclerosis (ALS), with current evidence for both, loss of function and pathological gain of function disease mechanisms. We screened 96 200 small molecules in C9ORF72 patient iPS neurons for modulation of nuclear G4C2 RNA foci and identified 82 validated hits, including the Brd4 inhibitor JQ1 as well as novel analogs of Spliceostatin-A, a known modulator of SF3B1, the branch point binding protein of the U2-snRNP. Spliceosome modulation by these SF3B1 targeted compounds recruits SRSF1 to nuclear G4C2 RNA, mobilizing it from RNA foci into nucleocytoplasmic export. This leads to increased repeat-associated non-canonical (RAN) translation and ultimately, enhanced cell toxicity. Our data (i) provide a new pharmacological entry point with novel as well as known, publicly available tool compounds for dissection of C9ORF72 pathobiology in C9ORF72 ALS models, (ii) allowing to differentially modulate RNA foci versus RAN translation, and (iii) suggest that therapeutic RNA foci elimination strategies warrant caution due to a potential storage function, counteracting translation into toxic dipeptide repeat polyproteins. Instead, our data support modulation of nuclear export via SRSF1 or SR protein kinases as possible targets for future pharmacological drug discovery.<\/jats:p>","DOI":"10.1093\/nar\/gkaf253","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:03:56Z","timestamp":1744279436000},"source":"Crossref","is-referenced-by-count":9,"title":["High-throughput screen of 100 000 small molecules in C9ORF72 ALS neurons identifies spliceosome modulators that mobilize G4C2 repeat RNA into nuclear export and repeat associated non-canonical translation"],"prefix":"10.1093","volume":"53","author":[{"given":"Maartje J","family":"Luteijn","sequence":"first","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Bhaskar","sequence":"additional","affiliation":[{"name":"Friedrich Miescher Institute for Biomedical Research , Department Genomic Regulation, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Trojer","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Sch\u00fcrz","sequence":"additional","affiliation":[{"name":"Paris-Lodron University of Salzburg, Department of Biosciences and Medical Biology, , Salzburg, 5020,","place":["Austria"]},{"name":"Ludwig Boltzmann Institute for Nanovesicular Precision Medicine at the Paris Lodron University Salzburg , 5020,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Mahboubi","sequence":"additional","affiliation":[{"name":"Friedrich Miescher Institute for Biomedical Research , Department Genomic Regulation, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Handl","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pizzato","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0776-6431","authenticated-orcid":false,"given":"Ruxandra","family":"Dafinca","sequence":"additional","affiliation":[{"name":"University of Oxford, John Radcliffe Hospital , Nuffield Department of Clinical Neurosciences, Oxford , OX3 9DU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Voshol","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Giorgetti","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Manneville","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle P M","family":"Garnier","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanning","family":"Zeng","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Buntin","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Markwalder","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Schr\u00f6der","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Weiler","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Khar","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Schuhmann","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Groot-Kormelink","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Gubser","family":"Keller","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Farmer","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"MacKay","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Beibel","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Roma","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"D\u2019Ario","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Merkl","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schebesta","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Discovery Sciences, Cambridge , MA 02139,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hild","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Discovery Sciences, Cambridge , MA 02139,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Elwood","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Discovery Sciences, Cambridge , MA 02139,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5159-5070","authenticated-orcid":false,"given":"Bj\u00f6rn F","family":"Vahsen","sequence":"additional","affiliation":[{"name":"ETH Z\u00fcrich, Department of Biology, Institute f. Molekularbiol.u.Biophysik , Z\u00fcrich , 8093,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ripin","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]},{"name":"ETH Z\u00fcrich, Department of Biology, Institute f. Molekularbiol.u.Biophysik , Z\u00fcrich , 8093,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Clery","sequence":"additional","affiliation":[{"name":"ETH Z\u00fcrich, Department of Biology, Institute f. Molekularbiol.u.Biophysik , Z\u00fcrich , 8093,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2131-6237","authenticated-orcid":false,"given":"Frederic","family":"Allain","sequence":"additional","affiliation":[{"name":"ETH Z\u00fcrich, Department of Biology, Institute f. Molekularbiol.u.Biophysik , Z\u00fcrich , 8093,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Labow","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Discovery Sciences, Cambridge , MA 02139,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-9156","authenticated-orcid":false,"given":"Jeffrey A","family":"Chao","sequence":"additional","affiliation":[{"name":"Friedrich Miescher Institute for Biomedical Research , Department Genomic Regulation, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1697","authenticated-orcid":false,"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[{"name":"University of Oxford, John Radcliffe Hospital , Nuffield Department of Clinical Neurosciences, Oxford , OX3 9DU,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Nash","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Hunziker","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0912-5902","authenticated-orcid":false,"given":"Nicole C","family":"Meisner-Kober","sequence":"additional","affiliation":[{"name":"Novartis Institutes for Biomedical Research , Department Global Discovery Chemistry, Basel , 4056,","place":["Switzerland"]},{"name":"Paris-Lodron University of Salzburg, Department of Biosciences and Medical Biology, , Salzburg, 5020,","place":["Austria"]},{"name":"Ludwig Boltzmann Institute for Nanovesicular Precision Medicine at the Paris Lodron University Salzburg , 5020,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2025041010001265100_B1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S1474-4422(18)30089-9","article-title":"Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model","volume":"17","author":"Westeneng","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025041010001265100_B2","first-page":"423","article-title":"Seminar amyotrophic lateral sclerosis","volume":"377","author":"Wales","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"2025041010001265100_B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"2025041010001265100_B4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"2025041010001265100_B5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"key":"2025041010001265100_B6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ajhg.2013.01.011","article-title":"Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population","volume":"92","author":"Beck","year":"2013","journal-title":"Am J Hum Genet"},{"key":"2025041010001265100_B7","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S1474-4422(13)70210-2","article-title":"Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study","volume":"12","author":"van\u00a0Blitterswijk","year":"2013","journal-title":"Lancet Neurol"},{"key":"2025041010001265100_B8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"2025041010001265100_B9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00401-013-1200-z","article-title":"C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci","volume":"126","author":"Mizielinska","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B10","doi-asserted-by":"publisher","DOI":"10.1038\/srep01016","article-title":"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes","volume":"2","author":"Fratta","year":"2012","journal-title":"Sci Rep"},{"key":"2025041010001265100_B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"2025041010001265100_B12","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1038\/s41467-021-25082-9","article-title":"Nuclear export and translation of circular repeat-containing intronic RNA in C9ORF72-ALS\/FTD","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"2025041010001265100_B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00401-015-1429-9","article-title":"Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy","volume":"130","author":"Cooper-Knock","year":"2015","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B14","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/nar\/gkv029","article-title":"Molecular mechanisms in DM1 - A focus on foci","volume":"43","author":"Pettersson","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025041010001265100_B15","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.3389\/fnins.2017.00711","article-title":"Unraveling the role of RNA mediated toxicity of C9orf72 repeats in C9-FTD\/ALS","volume":"11","author":"Kumar","year":"2017","journal-title":"Front Neurosci"},{"key":"2025041010001265100_B16","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018101112","article-title":"RNA toxicity in non-coding repeat expansion disorders","volume":"39","author":"Swinnen","year":"2020","journal-title":"EMBO J"},{"key":"2025041010001265100_B17","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1038\/s41467-023-41033-y","article-title":"Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"2025041010001265100_B18","doi-asserted-by":"publisher","first-page":"16063","DOI":"10.1038\/ncomms16063","article-title":"SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits","volume":"8","author":"Hautbergue","year":"2017","journal-title":"Nat Commun"},{"key":"2025041010001265100_B19","doi-asserted-by":"publisher","first-page":"e102700","DOI":"10.15252\/embj.2019102700","article-title":"The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD \/ALS","volume":"39","author":"Kawabe","year":"2020","journal-title":"EMBO J"},{"key":"2025041010001265100_B20","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"2025041010001265100_B21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"2025041010001265100_B23","doi-asserted-by":"publisher","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025041010001265100_B24","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","article-title":"Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins","volume":"126","author":"Mori","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B25","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"2025041010001265100_B26","doi-asserted-by":"publisher","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025041010001265100_B27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40478-020-01002-8","article-title":"The carboxyl termini of RAN translated GGGGCC nucleotide repeat expansions modulate toxicity in models of ALS\/FTD","volume":"8","author":"He","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2025041010001265100_B28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1093\/hmg\/ddx350","article-title":"C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity","volume":"30","author":"Lee","year":"2017","journal-title":"Hum Mol Genet"},{"key":"2025041010001265100_B29","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1126\/science.1256800","article-title":"C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins","volume":"345","author":"Mizielinska","year":"2014","journal-title":"Science"},{"key":"2025041010001265100_B30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.14348\/molcells.2020.0130","article-title":"C9orf72-associated arginine-rich dipeptide repeat proteins reduce the number of golgi outposts and dendritic branches in drosophila neurons","volume":"43","author":"Park","year":"2020","journal-title":"Mol Cells"},{"key":"2025041010001265100_B31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.neuron.2014.12.010","article-title":"Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS\/FTD form toxic nuclear aggregates that initiate invitro and invivo neuronal death","volume":"84","author":"Wen","year":"2014","journal-title":"Neuron"},{"key":"2025041010001265100_B32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nn.4272","article-title":"C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins","volume":"19","author":"Zhang","year":"2016","journal-title":"Nat Neurosci"},{"key":"2025041010001265100_B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/nature14974","article-title":"GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport","volume":"525","author":"Freibaum","year":"2015","journal-title":"Nature"},{"key":"2025041010001265100_B34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.ajhg.2015.04.016","article-title":"Jump from pre-mutation to pathologic expansion in C9orf72","volume":"96","author":"Xi","year":"2015","journal-title":"Am Hum Genet"},{"key":"2025041010001265100_B35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.neuron.2016.09.015","article-title":"Poly(GR) in C9ORF72-related ALS\/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons","volume":"92","author":"Lopez-Gonzalez","year":"2016","journal-title":"Neuron"},{"key":"2025041010001265100_B36","doi-asserted-by":"publisher","first-page":"e17820","DOI":"10.7554\/eLife.17820","article-title":"The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains","volume":"5","author":"Conlon","year":"2016","journal-title":"eLife"},{"key":"2025041010001265100_B37","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1093\/brain\/awu120","article-title":"Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions","volume":"137","author":"Cooper-Knock","year":"2014","journal-title":"Brain"},{"key":"2025041010001265100_B38","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1126\/science.1254917","article-title":"Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells","volume":"345","author":"Kwon","year":"2014","journal-title":"Science (1979)"},{"key":"2025041010001265100_B39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nn.4065","article-title":"Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS","volume":"18","author":"Prudencio","year":"2015","journal-title":"Nat Neurosci"},{"key":"2025041010001265100_B40","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.neuron.2019.11.007","article-title":"Antibody therapy targeting RAN proteins rescues C9 ALS\/FTD phenotypes in C9orf72 mouse model","volume":"105","author":"Nguyen","year":"2020","journal-title":"Neuron"},{"key":"2025041010001265100_B41","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/brain\/aww250","article-title":"Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia","volume":"139","author":"Vatsavayai","year":"2016","journal-title":"Brain"},{"key":"2025041010001265100_B42","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.neuron.2015.11.018","article-title":"Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice","volume":"88","author":"Peters","year":"2015","journal-title":"Neuron"},{"key":"2025041010001265100_B43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA-induced toxicity from the C9ORF72 ALS\/FTD repeat expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025041010001265100_B44","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/hmg\/ddz230","article-title":"Smcr8 deficiency disrupts axonal transport-dependent lysosomal function and promotes axonal swellings and gain of toxicity in C9ALS\/FTD mouse models","volume":"29","author":"Liang","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2025041010001265100_B45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat Med"},{"key":"2025041010001265100_B46","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41586-020-2633-x","article-title":"Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD","volume":"585","author":"Su","year":"2020","journal-title":"Nature"},{"key":"2025041010001265100_B47","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat Neurosci"},{"key":"2025041010001265100_B48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat Med"},{"key":"2025041010001265100_B49","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/nn.4085","article-title":"Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS","volume":"18","author":"Jovi\u010di\u010d","year":"2015","journal-title":"Nat Neurosci"},{"key":"2025041010001265100_B50","doi-asserted-by":"publisher","first-page":"445-57","DOI":"10.1007\/s00401-017-1798-3","article-title":"Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS\/FTD","volume":"135","author":"Moens","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00401-017-1796-5","article-title":"A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism","volume":"135","author":"Swinnen","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B52","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00401-017-1725-7","article-title":"In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers","volume":"134","author":"DeJesus-Hernandez","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B53","doi-asserted-by":"publisher","first-page":"208ra149","DOI":"10.1126\/scitranslmed.3007529","article-title":"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion","volume":"5","author":"Sareen","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025041010001265100_B54","doi-asserted-by":"publisher","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2025041010001265100_B55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41467-021-21112-8","article-title":"Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"2025041010001265100_B56","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/WCO.0000000000000594","article-title":"Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis","volume":"31","author":"Ly","year":"2018","journal-title":"Curr Opin Neurol"},{"key":"2025041010001265100_B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41591-021-01557-6","article-title":"Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide","volume":"28","author":"Tran","year":"2022","journal-title":"Nat Med"},{"key":"2025041010001265100_B58","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1474-4422(24)00216-3","article-title":"Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study","volume":"23","author":"van","year":"2024","journal-title":"Lancet Neurol"},{"key":"2025041010001265100_B59","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.omtn.2022.04.007","article-title":"Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD","volume":"28","author":"Liu","year":"2022","journal-title":"Mol Ther - Nucleic Acids"},{"key":"2025041010001265100_B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-023-02652-3","article-title":"G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS\/FTD induced pluripotent stem cell derived neurons","volume":"147","author":"Rothstein","year":"2023","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B61","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/hmg\/ddaa106","article-title":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR\/Cas9 genome editing using homology-directed repair","volume":"29","author":"Ababneh","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2025041010001265100_B62","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","article-title":"CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro","volume":"13","author":"Meijboom","year":"2022","journal-title":"Nat Commun"},{"key":"2025041010001265100_B63","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1038\/s41598-022-07746-8","article-title":"Dual-gRNA approach with limited off-target effect corrects C9ORF72 repeat expansion in vivo","volume":"12","author":"Piao","year":"2022","journal-title":"Sci Rep"},{"key":"2025041010001265100_B64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.15252\/emmm.201707850","article-title":"G-quadruplex-binding small molecules ameliorate C9orf72 FTD\/ALS pathology in vitro and in vivo","volume":"10","author":"Simone","year":"2018","journal-title":"EMBO Mol Med"},{"key":"2025041010001265100_B65","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"},{"key":"2025041010001265100_B66","doi-asserted-by":"publisher","first-page":"eabd5991","DOI":"10.1126\/SCITRANSLMED.ABD5991","article-title":"Ribonuclease recruitment using a small molecule reduced c9ALS\/FTD r(G4C2) repeat expansion in vitro and in vivo ALS models","volume":"13","author":"Bush","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025041010001265100_B67","doi-asserted-by":"publisher","first-page":"18624","DOI":"10.1074\/jbc.RA119.009951","article-title":"High-throughput screening yields several small-molecule inhibitors of repeat-associated non-AUG translation","volume":"294","author":"Green","year":"2019","journal-title":"J Biol Chem"},{"key":"2025041010001265100_B68","doi-asserted-by":"publisher","article-title":"Small molecule inhibition of PIKFYVE kinase rescues gain- and loss-of-function C9ORF72 ALS\/FTD disease processes invivo","author":"Staats","DOI":"10.1101\/685800"},{"key":"2025041010001265100_B69","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat Med"},{"key":"2025041010001265100_B70","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.stemcr.2020.03.023","article-title":"Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS\/FTD","volume":"14","author":"Dafinca","year":"2020","journal-title":"Stem Cell Rep"},{"key":"2025041010001265100_B71","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/hmg\/ddaa106","article-title":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR\/Cas9 genome editing using homology-directed repair","volume":"29","author":"Ababneh","year":"2020","journal-title":"Hum Mol Genet"},{"key":"2025041010001265100_B72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.drudis.2015.08.001","article-title":"Identifying compound efficacy targets in phenotypic drug discovery","volume":"21","author":"Schirle","year":"2016","journal-title":"Drug Discovery Today"},{"key":"2025041010001265100_B73","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1093\/nar\/gkx136","article-title":"Comparative analyses of the thermodynamic RNA binding signatures of different types of RNA recognition motifs","volume":"45","author":"Samatanga","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2025041010001265100_B74","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.molcel.2015.09.005","article-title":"SRSF1-Regulated alternative splicing in breast cancer","volume":"60","author":"Anczuk\u00f3w","year":"2015","journal-title":"Mol Cell"},{"key":"2025041010001265100_B75","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025041010001265100_B76","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1038\/nrn.2016.38","article-title":"The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease","volume":"17","author":"Haeusler","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"2025041010001265100_B77","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2025041010001265100_B78","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ymeth.2006.06.010","article-title":"Nuclear and cytoplasmic mRNA quantification by SYBR green based real-time RT-PCR","volume":"39","author":"Wang","year":"2006","journal-title":"Methods"},{"key":"2025041010001265100_B79","doi-asserted-by":"crossref","first-page":"e12282","DOI":"10.1002\/jev2.12282","article-title":"EVAnalyzer: high content imaging for rigorous characterisation of single extracellular vesicles using standard laboratory equipment and a new open-source ImageJ\/Fiji plugin","volume":"11","author":"Sch\u00fcrz","year":"2022","journal-title":"J Extracell Vesicles"},{"key":"2025041010001265100_B80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nbt.3049","article-title":"Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes","volume":"33","author":"Maury","year":"2015","journal-title":"Nat Biotechnol"},{"key":"2025041010001265100_B81","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/stem.2388","article-title":"C9orf72 Hexanucleotide expansions are associated with altered endoplasmic reticulum calcium homeostasis and stress granule formation in induced pluripotent stem cell-derived neurons from patients with amyotrophic lateral sclerosis and frontotemporal demen","volume":"34","author":"Dafinca","year":"2016","journal-title":"Stem Cells"},{"key":"2025041010001265100_B82","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"2025041010001265100_B83","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.expneurol.2015.06.017","article-title":"Bromodomain inhibitors regulate the C9ORF72 locus in ALS","volume":"271","author":"Zeier","year":"2015","journal-title":"Exp Neurol"},{"key":"2025041010001265100_B84","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1101\/gad.2014311","article-title":"Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A","volume":"25","author":"Corrionero","year":"2011","journal-title":"Genes Dev"},{"key":"2025041010001265100_B85","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41467-017-02007-z","article-title":"Molecular basis of differential 3\u2032 splice site sensitivity to anti-tumor drugs targeting U2 snRNP","volume":"8","author":"Vigevani","year":"2017","journal-title":"Nat Commun"},{"key":"2025041010001265100_B86","doi-asserted-by":"publisher","first-page":"10.1002\/wrna.1381","DOI":"10.1002\/wrna.1381","article-title":"Modulating splicing with small molecular inhibitors of the spliceosome","volume":"8","author":"Effenberger","year":"2017","journal-title":"WIREs RNA"},{"key":"2025041010001265100_B87","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1021\/ol4024634","article-title":"Enantioselective syntheses of FR901464 and spliceostatin A: potent inhibitors of spliceosome","volume":"15","author":"Ghosh","year":"2013","journal-title":"Org Lett"},{"key":"2025041010001265100_B88","doi-asserted-by":"publisher","first-page":"6664","DOI":"10.1093\/nar\/gkq494","article-title":"Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation","volume":"38","author":"Roybal","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2025041010001265100_B89","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.chembiol.2021.03.002","article-title":"Spliceostatin A interaction with SF3B limits U1 snRNP availability and causes premature cleavage and polyadenylation","volume":"28","author":"Yoshimoto","year":"2021","journal-title":"Cell Chem Biol"},{"key":"2025041010001265100_B90","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nchembio.2007.18","article-title":"Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA","volume":"3","author":"Kaida","year":"2007","journal-title":"Nat Chem Biol"},{"key":"2025041010001265100_B91","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1074\/jbc.M113.515536","article-title":"Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide b and its analogs","volume":"289","author":"Effenberger","year":"2014","journal-title":"J Biol Chem"},{"key":"2025041010001265100_B92","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1261\/rna.065383.117","article-title":"Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping","volume":"24","author":"Wu","year":"2018","journal-title":"RNA"},{"key":"2025041010001265100_B93","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41467-017-02007-z","article-title":"Molecular basis of differential 3\u2032 splice site sensitivity to anti-tumor drugs targeting U2 snRNP","volume":"8","author":"Vigevani","year":"2017","journal-title":"Nat Commun"},{"key":"2025041010001265100_B94","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1021\/cb300602j","article-title":"Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells","volume":"8","author":"Gao","year":"2013","journal-title":"ACS Chem Biol"},{"key":"2025041010001265100_B95","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1242\/jcs.202200","article-title":"Pharmacological inhibition of the spliceosome subunit SF3b triggers exon junction complex-independent nonsense-mediated decay","volume":"130","author":"Carvalho","year":"2017","journal-title":"J Cell Sci"},{"key":"2025041010001265100_B96","first-page":"1519","article-title":"Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells","volume":"345","author":"Kwon","year":"2014","journal-title":"Science (1979)"},{"key":"2025041010001265100_B97","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nmeth.2305","article-title":"Single-molecule analysis of gene expression using two-color RNA labeling in live yeast","volume":"10","author":"Hocine","year":"2013","journal-title":"Nat Methods"},{"key":"2025041010001265100_B98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13024-021-00475-y","article-title":"SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis","volume":"16","author":"Castelli","year":"2021","journal-title":"Mol Neurodegener"},{"key":"2025041010001265100_B99","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1093\/nar\/gkae473","article-title":"Crystal structure of a tetrameric RNA G-quadruplex formed by hexanucleotide repeat expansions of C9orf72 in ALS\/FTD","volume":"52","author":"Geng","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2025041010001265100_B100","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1038\/s41467-023-43872-1","article-title":"The ALS\/FTD-related C9orf72 hexanucleotide repeat expansion forms RNA condensates through multimolecular G-quadruplexes","volume":"14","author":"Raguseo","year":"2023","journal-title":"Nat Commun"},{"key":"2025041010001265100_B101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"2025041010001265100_B102","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1017\/S1355838200000078","article-title":"REF, an evolutionarily conserved family of hnRNP-like proteins, interacts with TAP\/Mex67p and participates in mRNA nuclear export","volume":"6","author":"Stutz","year":"2000","journal-title":"RNA"},{"key":"2025041010001265100_B103","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13059-015-0682-5","article-title":"Differential connectivity of splicing activators and repressors to the human spliceosome","volume":"16","author":"Akerman","year":"2015","journal-title":"Genome Biol"},{"key":"2025041010001265100_B104","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00401-017-1798-3","article-title":"Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS\/FTD","volume":"135","author":"Moens","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2025041010001265100_B105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41588-018-0070-7","article-title":"CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity","volume":"50","author":"Kramer","year":"2018","journal-title":"Nat Genet"},{"key":"2025041010001265100_B106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.chembiol.2018.10.020","article-title":"A chemical screen identifies compounds limiting the toxicity of C9ORF72 dipeptide repeats","volume":"26","author":"Corman","year":"2019","journal-title":"Cell Chem Biol"},{"key":"2025041010001265100_B107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ncomms15522","article-title":"Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex","volume":"8","author":"Teng","year":"2017","journal-title":"Nat Commun"},{"key":"2025041010001265100_B108","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.15252\/embr.201541116","article-title":"The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches","volume":"16","author":"Daguenet","year":"2015","journal-title":"EMBO Rep"},{"key":"2025041010001265100_B109","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nchembio.2007.16","article-title":"Splicing factor SF3b as a target of the antitumor natural product pladienolide","volume":"3","author":"Kotake","year":"2007","journal-title":"Nat Chem Biol"},{"key":"2025041010001265100_B110","first-page":"570","article-title":"C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins","volume":"1192","author":"Mizielinska","year":"2014","journal-title":"Science (1979)"},{"key":"2025041010001265100_B111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2014.10.030","article-title":"Functional splicing network reveals extensive regulatory potential of the core spliceosomal machinery","volume":"57","author":"Papasaikas","year":"2015","journal-title":"Mol Cell"},{"key":"2025041010001265100_B112","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2008.03.013","article-title":"The splicing factor SF2\/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1","volume":"30","author":"Michlewski","year":"2008","journal-title":"Mol Cell"},{"key":"2025041010001265100_B113","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neuron.2015.09.015","article-title":"Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a drosophila model of C9ORF72 FTD\/ALS","volume":"87","author":"Tran","year":"2015","journal-title":"Neuron"},{"key":"2025041010001265100_B114","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jamaneurol.2015.1872","article-title":"Cortical function in asymptomatic carriers and patients with C9orf72 amyotrophic lateral sclerosis","volume":"72","author":"Geevasinga","year":"2015","journal-title":"JAMA Neurol"},{"key":"2025041010001265100_B115","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.neuron.2017.07.029","article-title":"Lost in transportation: nucleocytoplasmic transport defects in ALS and other neurodegenerative diseases","volume":"96","author":"Kim","year":"2017","journal-title":"Neuron"},{"key":"2025041010001265100_B116","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.2217\/rme-2020-0067","article-title":"Modeling ALS using iPSCs: is it possible to reproduce the phenotypic variations observed in patients in vitro?","volume":"15","author":"Vasques","year":"2020","journal-title":"Regen Med"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/7\/gkaf253\/62902838\/gkaf253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/53\/7\/gkaf253\/62902838\/gkaf253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T10:03:59Z","timestamp":1744279439000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/doi\/10.1093\/nar\/gkaf253\/8109939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,4,10]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkaf253","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,24]]},"published":{"date-parts":[[2025,4,10]]},"article-number":"gkaf253"}}